Study details
Enrolling now
Effect of a Daily Supplement on Plasma PAI-1 Levels
University of California, Los Angeles
NCT IDNCT07469475ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1/2
Ages
18+
Locations
2 sites in CA
What this study is about
This Phase 1/Phase 2 study is testing Supplement in people with aging.
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Standard assignment
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
dietary supplement, Dermatological Agents (Immunologic Factor Interactions)
Drug routes
oral (Oral Capsule)
Endpoints
Secondary: Change in Blood Level of C-Reactive Protein Between Baseline and 6 Months, Change in Blood Pressure Between Baseline and 6 Months